Mefasil 250 Tablet contains Mefenamic Acid 250mg, a well-established non-steroidal anti-inflammatory drug (NSAID) indicated for the management of mild to moderate pain conditions such as dysmenorrhea, dental pain, headache, musculoskeletal pain, and post-operative discomfort. It helps in reducing pain intensity and improving patient comfort.
Mefenamic Acid works by inhibiting cyclooxygenase (COX) enzymes, thereby reducing the synthesis of prostaglandins responsible for pain, inflammation, and fever. This mechanism ensures effective analgesic and anti-inflammatory action with rapid symptomatic relief.
For distributors and healthcare suppliers, Mefasil 250 Tablet is a high-rotation pain management product, commonly prescribed by gynecologists, dentists, orthopedists, and general physicians. Its wide therapeutic usage ensures consistent demand across outpatient and pharmacy settings.
Adding Mefasil 250 Tablet to your pain management and anti-inflammatory therapy segment creates strong opportunities in pharmacies, hospitals, specialty clinics, export markets, and third-party manufacturing. Its proven efficacy, broad clinical acceptance, and reliable pain relief profile make it a valuable addition to pharmaceutical distribution portfolios.